Back

Ipratropium Bromide

Ipratropium inhalation is used to prevent bronchospasm, or narrowing airways in the lungs, in people with bronchitis, emphysema, or COPD (chronic obstructive pulmonary disease)

Ipratropium Bromidebelongs to Anti-Asthmatic Therapeutic Category.

Aarti Healthcare Division of Aarti Industries Limited manufactures Ipratropium with an annual capacity of 6000 Kgs.

Ipratropium is available in the following Specifications/Grades.

Specification EP/BP
EDMF (CTD) CEP 2008-150
USDMF 21179
COS RO-CEP 2008-150-REV 01

 

One of the principles that enables Aarti to offer our customers the utmost in supply reliability and to further consolidate our competitive position is our backward integration of all the key intermediates that go into manufacturing of APIs.

ANTI ASTHAMATIC
Budesonide Bambuterol HCL R-Salbutamol Sulphate
Levalbuterol HCL Levalbuterol Tartrate Salmeterol Xinafoate
Ipratropium Bromide Ciclesonide Fluticasone Propionate
Fluticasone Furoate Mometasone Furoate Monohydrate Formoterol Fumarate

 

Note :

  1. Intermediates of above APIs will be available.
  2. Products Under Patent will not be sold until patent expiration in buyer's country.
  3. Purchase of any Patented Product will be sole responsibility of the Buyer.

Top